You may also like
Malignant Hyperthermia Following Systemic Rewarming after Hypothermic Cardiopulmonary Bypass
We describe a patient with a suspected family history of MH
DeCODE and Roche Plan Gene Test for Heart Attack Risk
LONDON (Reuters) – Iceland’s deCODE genetics Inc and Swiss group Roche Holding AG said on Friday they planned to develop a DNA-based […]
Anticoagulation and Transfusion Management During Neonatal and Pediatric Extracorporeal Membrane Oxygenation: A Survey of Medical Directors in the United States
Compared with the 2013 pediatric population, extracorporeal membrane oxygenation center anticoagulation and blood transfusion approaches continue to vary widely. Most report continued use of heparin as their primary anticoagulant and follow a combination of monitoring assays with the majority using the antifactor Xa assay in their practices, a significant shift from prior results. Antithrombin activity levels and viscoelastic tests are followed by a growing number of centers. Platelet transfusion thresholds continue to vary widely. Future research is needed to establish optimal anticoagulation and blood transfusion management.
